CHEAP MJ PLAY$51 million marketcap.
Now have a look at the comps out there TRADING at $200 million plus.
Buy ahead of future milestones:
- Sales licence -- WeedMD has completed the review and inspection process with Health Canada and is currently awaiting results that, if approved, would allow it to sell dried flower product to patients. The company expects to receive its sales licence in the second quarter of 2017.
- Commercial extraction laboratory -- WeedMD will commence building out a commercial extraction laboratory and expects construction to be completed in the second quarter of 2017.
- Extracts production licence -- WeedMD will apply for an amendment to its ACMPR licence to allow the company to begin medical cannabis oil production upon the successful completion and buildout of its extracts lab. Assuming buildout of the lab in Q2 2017, WeedMD expects to receive an amendment allowing for extract production in the summer of 2017.
- Expansion plan -- With building permits approved and in place, WeedMD's next phase of growth is to expand from 26,000 square feet to over 220,000 square feet. The company has an additional 100 acres of nearby land for potential future expansion, and is actively looking at alternatives to accelerate go-to-market as Canada's recreational market is expected to launch on or before July 1, 2018.